Clinical trials query results
From Health Canada
- Medical condition:
- TREATMENT RESISTANT DEPRESSION
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- THE EFFICACY AND TOLERABILITY OF PSILOCYBIN IN PARTICIPANTS WITH TREATMENT-RESISTANT DEPRESSION: A PHASE 2, RANDOMIZED FEASIBILITY STUDY
- Sponsor name:
- BRAIN AND COGNITION DISCOVERY FOUNDATION
- Date of no objection letter:
- 2021-07-12
- Control number:
- 253490
- Trial status:
- CLOSED
- Date study started:
- 2021-10-13
- Date study completed:
- 2023-07-22